Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma

NCT01844076 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
19
Enrollment
OTHER
Sponsor class

Stopped The single Quinacrine manufacture facility in the US was shut down by the FDA

Conditions

Interventions

Sponsor

Fox Chase Cancer Center